EGK BioMedic Series

EGK BioMedic Series is an AI-powered biomedical intelligence platform from EGK Microelectronic Solutions Group’s IsaacLab Division, developed in Penang, Malaysia. It is described as a suite of six applications built to serve Malaysia’s healthcare and research sectors, covering drug safety, molecular visualization, protein simulation, pharmacokinetics, genomics, and clinical research.

The portfolio is split into two sets of applications. One group focuses on drug discovery intelligence: EGK AIDrugCheck provides drug interaction intelligence with clinical safety insights, including detection of dangerous drug combinations, severity classification from minor to life-threatening, and pharmacological explanations for pharmacists, clinical educators, and safety-conscious practitioners. EGK AIProteinSim offers real-time 3D protein binding simulation and visualization using RCSB Protein Data Bank structures or custom PDB files, with predictions of binding affinity, free energy calculations, and molecular interactions. EGK MoleculeView AI provides 3D molecular visualization and SMILES parsing, along with pharmaceutical analysis such as Lipinski Rule-of-5 and QED drug-likeness scoring. Another group covers research and analysis: EGK AIGenesAnalyze imports DESeq2 or edgeR CSVs to generate volcano plots and heatmaps with pathway enrichment analysis; EGK PharmaKinetic supports pharmacokinetic modeling and PK/PD simulation, including half-life, clearance, volume of distribution, AUC breakdown, and multi-drug PK comparison; and EGK Clinical tracks Phase I–IV trials worldwide, with AI-summarized outcomes, adverse event classification, recruitment criteria, and live safety signal detection.

The site states that the series is powered by xAI Grok and deployable across iOS, macOS, and Windows, with app listings shown for the App Store and Google Play. It also presents the platform as a cohesive biomedical AI ecosystem with 3D molecular visualization and research-grade analytics.